ECM sclerosis has been shown to promote FERMT2 translocation to mitochondria and its interaction with pyrroline-5-carboxylate reductase 1 (PYCR1), which regulates crosstalk between the tumor and its microenvironment in breast cancer [73]. The gene discussed is FERMT2; the disease is neoplasm.